Blueprint
 
FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 
 
 
For period ending 27 November 2018
 
GlaxoSmithKline plc
(Name of registrant)
 
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 
 
Form 20-F x     Form 40-F
 
--
 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
 
Yes      No x
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
Date: 27 November 2018
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
 
Period of return:
 
From:
 
1 May 2018
 
To:
 
31 October 2018
 
Balance of unallotted securities under scheme(s) from previous return:
 
Previous balance: 33,863*
Restated balance: -27,669
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
575,000
 
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
0
 
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
 
547,331
 
 
 
 
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
*Due to clerical error the opening balance has been restated.

 
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
Date: 27 November 2018
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline Share Option Plan - Ordinary Shares
 
Period of return:
 
From:
 
1 May 2018
 
To:
 
31 October 2018
 
Balance of unallotted securities under scheme(s) from previous return:
 
Previous balance: 2,693,951*
Restated balance: 2,755,483
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
532,131
 
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
 
2,223,352
 
 
 
 
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
*Due to clerical error the opening balance has been restated.
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
Date: 27 November 2018
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline Share Option Plan - ADS
 
Period of return:
 
From:
 
1 May 2018
 
To:
 
31 October 2018
 
Balance of unallotted securities under scheme(s) from previous return:
 
7,909,994
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
0
 
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
573,898
 
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
 
7,336,096
 
 
 
 
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
Information provided on this form must be typed or printed electronically and provided to an ris.
 
Date: 27 November 2018
 
Name of applicant:
 
GlaxoSmithKline plc
 
Name of scheme:
 
GlaxoSmithKline plc Share Save Plan 2012
 
Period of return:
 
From:
 
1 May 2018
 
To:
 
31 October 2018
 
Balance of unallotted securities under scheme(s) from previous return:
 
827,306
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
 
5,000,000
 
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
 
154,683
 
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
 
5,672,623
 
 
 
 
 
 
 
Name of contact:
 
Victoria Whyte
 
Telephone number of contact:
 
020 8047 5000
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GlaxoSmithKline plc
 
(Registrant)
 
 
Date: November 27, 2018 
 
 
 
 
By: VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GlaxoSmithKline plc